deltatrials
Completed PHASE1 NCT00518466

Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese Adults

A Phase Ib, Open Label, Parallel-Design Single- and Multiple-Dose Study Comparing Modified Release Topiramate Formulations to Immediate Release Formulations of Topiramate Dosed in Combination With Immediate Release Phentermine in Obese Adults

Sponsor: VIVUS LLC

Conditions Obesity
Interventions phentermine topiramate
Updated 6 times since 2017 Last updated: Jun 6, 2011 Started: Jul 31, 2007 Primary completion: Sep 30, 2007 Completion: Dec 31, 2007

This PHASE1 trial investigates Obesity and is currently completed. VIVUS LLC leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE1

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • VIVUS LLC
Data source: VIVUS LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Mountain View, United States